High Economic Burden Yet Low Clinical Value: Why Is so Much Sucralfate Prescribed?
Basic & Clinical Pharmacology & Toxicology · 2025-07 · 137 (1)
DOI: 10.1111/bcpt.70070 ↗At a glance
Übersichtsarbeit in Basic & Clinical Pharmacology & Toxicology, published online on 2025-06-13. Written by Neha Wadhavkar and 2 co-authors. Institution: Department of Internal Medicine, Brown University, Providence, Rhode Island, USA. Major MEDLINE topics: Sucralfate, Anti-Ulcer Agents, Gastrointestinal Diseases. Cited 1 times so far (Crossref); 11 references.
Abstract (original language)
Sucralfate is a commonly prescribed medication in use for decades. Despite the availability of more effective medications for acid‐dyspeptic conditions, including proton pump inhibitors and histamine H2‐receptor antagonists, sucralfate continues to be utilized for upper gastrointestinal symptoms. We reviewed the limited evidence base supporting the approval and ongoing usage of sucralfate and performed a cost analysis using the ClinCalc database. The financial impact of sucralfate was comparable to famotidine, lansoprazole and ranitidine. We encourage further studies to accurately gauge the true clinical efficacy of sucralfate and to question its ongoing prescription until then.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Internal Medicine, Brown University, Providence, Rhode Island, USA.
- UMass Memorial Specialty Pharmacy, UMass Memorial Medical Center, Worcester, Massachusetts, USA.
- Division of Gastroenterology, Brown University, Providence, Rhode Island, USA.
ORCID profiles: Neha Wadhavkar
Cite
APA
Wadhavkar, N., Varnum, L., & Moss, S. F. (2025). High Economic Burden Yet Low Clinical Value: Why Is so Much Sucralfate Prescribed?. Basic & Clinical Pharmacology & Toxicology, 137(1). https://doi.org/10.1111/bcpt.70070
Vancouver
Wadhavkar N, Varnum L, Moss SF. High Economic Burden Yet Low Clinical Value: Why Is so Much Sucralfate Prescribed?. Basic & Clinical Pharmacology & Toxicology. 2025;137(1). doi:10.1111/bcpt.70070
BibTeX
@article{Wadhavkar2025,
author = {Wadhavkar, Neha and Varnum, Laura and Moss, Steven F},
title = {High Economic Burden Yet Low Clinical Value: Why Is so Much Sucralfate Prescribed?},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
volume = {137},
number = {1},
doi = {10.1111/bcpt.70070}
}
EUVIMED